PharmaEngine, Inc. is a biopharmaceutical company established in Taipei, Taiwan in 2003, and funded by TTY Biopharm and Taiwan venture capitals. PharmaEngine adopts the business model of “no research, development only” and focuses on the development of new drugs for the treatment of cancer and Asian prevalent diseases. In 2003, PharmaEngine licensed the exclusive rights to develop and commercialize PEP02 in Asia from Hermes Biosciences, Inc. (South San Francisco, CA), and subsequently expanded the territory to Europe in 2005.
Headquarters
11F, 10 Minsheng E. Road, Sec. 3
Taipei City; Taipei City;
Contact Details: Purchase the PharmaEngine, Inc. (智擎生技制药股份有限公司) report to view the information.
Website: http://www.pharmaengine.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service